Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mannitol for Postreperfusion Syndrome in Living Donor Liver Transplant
NCT05277623Phase 1Completed
- Sponsor
- Ain Shams University
- Start
- Apr 2022
- Primary completion
- Nov 2022
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of Bronchitol in Post-reperfusion syndrome (PRS) (2 arms), sponsored by Ain Shams University. Primary endpoint: Mean Arterial Blood Pressure. Started Apr 2022; status: completed.
02
Drugs
Bronchitol
03
Conditions
Post-reperfusion syndrome (PRS)
Beyond the preview
Go deeper on NCT05277623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05277623.